LBO — ST. RITAS MEDICAL CENTER LLC
IRR: 20.1% | MOIC: 2.49x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
20.1%
IRR
2.49x
MOIC
$330.7M
Entry EV
$569.1M
Exit EV
$170.2M
Equity Invested
Sources & Uses
S&UTotal · $330.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $128.4M | 38.8% | |
| Sub Debt | $32.1M | 9.7% | |
| Equity | $170.2M | 51.5% | |
| Enterprise Value | $321.1M | 97.1% | |
| Transaction Fees | $9.6M | 2.9% | |
| Total Uses | $330.7M | 100.0% |
Interpretation
INTAt 2.49x MOIC and 20.1% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $54.2M |
| Exit Ev | $569.1M |
| Net Debt At Exit | $144.8M |
| Equity At Exit | $424.3M |
| Equity Invested | $170.2M |
| Total Value Created | $254.1M |
| Value From Growth | $231.9M |
| Value From Multiple | $16.1M |
| Value From Deleveraging | $15.7M |